Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: A current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke

  1. Sulzgruber, P.
  2. Wassmann, S.
  3. Semb, A.G.
  4. Doehner, W.
  5. Widimsky, P.
  6. Gremmel, T.
  7. Kaski, J.C.
  8. Savarese, G.
  9. Rosano, G.M.C.
  10. Borghi, C.
  11. Kjeldsen, K.
  12. Torp-Pedersen, C.
  13. Schmidt, T.A.
  14. Lewis, B.S.
  15. Drexel, H.
  16. Tamargo, J.
  17. Atar, D.
  18. Agewall, S.
  19. Niessner, A.
Revue:
European Heart Journal - Cardiovascular Pharmacotherapy

ISSN: 2055-6845 2055-6837

Année de publication: 2019

Volumen: 5

Número: 3

Pages: 171-180

Type: Révision

DOI: 10.1093/EHJCVP/PVZ016 GOOGLE SCHOLAR